FDA Warning Letter — Rx-Mart Pharmacy

Case 518765 — FEI 3013311548

The FDA took a Warning Letter action against Rx-Mart Pharmacy on Mar 2, 2017 (Bellingham, WA). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Rx-Mart Pharmacy
Date
Mar 2, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Bellingham, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.